Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 172

1.

Treatment related factors and inhibitor development in children with severe haemophilia A.

Maclean PS, Richards M, Williams M, Collins P, Liesner R, Keeling DM, Yee T, Will AM, Young D, Chalmers EA; Paediatric Working Party of UKHCDO.

Haemophilia. 2011 Mar;17(2):282-7. doi: 10.1111/j.1365-2516.2010.02422.x. Epub 2010 Nov 11.

PMID:
21070501
[PubMed - indexed for MEDLINE]
2.

Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.

Gouw SC, Van Der Bom JG, Van Den Berg HM, Zewald RA, Ploos Van Amstel JK, Mauser-Bunschoten EP.

Haemophilia. 2011 Mar;17(2):275-81. doi: 10.1111/j.1365-2516.2010.02420.x. Epub 2010 Nov 11.

PMID:
21070499
[PubMed - indexed for MEDLINE]
3.

Immune response to FVIII in hemophilia A: an overview of risk factors.

Ghosh K, Shetty S.

Clin Rev Allergy Immunol. 2009 Oct;37(2):58-66. doi: 10.1007/s12016-009-8118-1. Review.

PMID:
19148784
[PubMed - indexed for MEDLINE]
4.

Risk of inhibitor development in mild haemophilia A increases with age.

Mauser-Bunschoten EP, Den Uijl IE, Schutgens RE, Roosendaal G, Fischer K.

Haemophilia. 2012 Mar;18(2):263-7. doi: 10.1111/j.1365-2516.2011.02629.x. Epub 2011 Aug 19.

PMID:
21851507
[PubMed - indexed for MEDLINE]
5.

Environmental risk factors for inhibitor development in children with haemophilia A: a case-control study.

Santagostino E, Mancuso ME, Rocino A, Mancuso G, Mazzucconi MG, Tagliaferri A, Messina M, Mannucci PM.

Br J Haematol. 2005 Aug;130(3):422-7.

PMID:
16042693
[PubMed - indexed for MEDLINE]
6.

Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A.

Chalmers EA, Brown SA, Keeling D, Liesner R, Richards M, Stirling D, Thomas A, Vidler V, Williams MD, Young D; Paediatric Working Party of UKHCDO.

Haemophilia. 2007 Mar;13(2):149-55.

PMID:
17286767
[PubMed - indexed for MEDLINE]
7.

New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development.

Kurnik K, Bidlingmaier C, Engl W, Chehadeh H, Reipert B, Auerswald G.

Haemophilia. 2010 Mar;16(2):256-62. doi: 10.1111/j.1365-2516.2009.02122.x. Epub 2009 Oct 29.

PMID:
19878331
[PubMed - indexed for MEDLINE]
8.

Inhibitors: our greatest challenge. Can we minimize the incidence?

Kruse-Jarres R.

Haemophilia. 2013 Jan;19 Suppl 1:2-7. doi: 10.1111/hae.12049. Review.

PMID:
23278993
[PubMed - indexed for MEDLINE]
9.

Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A.

Gouw SC, van den Berg HM, le Cessie S, van der Bom JG.

J Thromb Haemost. 2007 Jul;5(7):1383-90. Epub 2007 Apr 20.

PMID:
17456190
[PubMed - indexed for MEDLINE]
10.

Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE®).

Bacon CL, Singleton E, Brady B, White B, Nolan B, Gilmore RM, Ryan C, Keohane C, Jenkins PV, O'Donnell JS.

Haemophilia. 2011 May;17(3):407-11. doi: 10.1111/j.1365-2516.2010.02430.x. Epub 2011 Mar 8.

PMID:
21382134
[PubMed - indexed for MEDLINE]
11.

Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age.

Lorenzo JI, López A, Altisent C, Aznar JA.

Br J Haematol. 2001 Jun;113(3):600-3.

PMID:
11380444
[PubMed - indexed for MEDLINE]
12.

Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies.

Coppola A, Santoro C, Tagliaferri A, Franchini M, DI Minno G.

Haemophilia. 2010 Jan;16 Suppl 1:13-9. doi: 10.1111/j.1365-2516.2009.02175.x. Review.

PMID:
20059564
[PubMed - indexed for MEDLINE]
13.

The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.

Greninger DA, Saint-Remy JM, Jacquemin M, Benhida A, DiMichele DM.

Haemophilia. 2008 Mar;14(2):295-302. Epub 2007 Dec 12.

PMID:
18081826
[PubMed - indexed for MEDLINE]
14.

The multifactorial etiology of inhibitor development in hemophilia: genetics and environment.

Gouw SC, van den Berg HM.

Semin Thromb Hemost. 2009 Nov;35(8):723-34. doi: 10.1055/s-0029-1245105. Epub 2010 Feb 18. Review.

PMID:
20169509
[PubMed - indexed for MEDLINE]
15.

Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.

Boekhorst J, Lari GR, D'Oiron R, Costa JM, Nováková IR, Ala FA, Lavergne JM, VAN Heerde WL.

Haemophilia. 2008 Jul;14(4):729-35. doi: 10.1111/j.1365-2516.2008.01694.x. Epub 2008 May 12.

PMID:
18503540
[PubMed - indexed for MEDLINE]
16.

Intensive peri-operative use of factor VIII and the Arg593-->Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A.

Eckhardt CL, Menke LA, van Ommen CH, van der Lee JH, Geskus RB, Kamphuisen PW, Peters M, Fijnvandraat K.

J Thromb Haemost. 2009 Jun;7(6):930-7. doi: 10.1111/j.1538-7836.2009.03357.x.

PMID:
19548904
[PubMed - indexed for MEDLINE]
17.

Haemophilia care in children--benefits of early prophylaxis for inhibitor prevention.

Mancuso ME, Graca L, Auerswald G, Santagostino E.

Haemophilia. 2009 Jan;15 Suppl 1:8-14. doi: 10.1111/j.1365-2516.2008.01947.x. Review.

PMID:
19125935
[PubMed - indexed for MEDLINE]
18.

The epidemiology of factor VIII inhibitors.

Hay CR.

Haemophilia. 2006 Dec;12 Suppl 6:23-8; discussion 28-9. Review.

PMID:
17123390
[PubMed - indexed for MEDLINE]
19.

Recombinant factor concentrates may increase inhibitor development: a single centre cohort study.

Strauss T, Lubetsky A, Ravid B, Bashari D, Luboshitz J, Lalezari S, Misgav M, Martinowitz U, Kenet G.

Haemophilia. 2011 Jul;17(4):625-9. doi: 10.1111/j.1365-2516.2010.02464.x. Epub 2011 Feb 7.

PMID:
21299743
[PubMed - indexed for MEDLINE]
20.

Forum on: the role of recombinant factor VIII in children with severe haemophilia A.

Franchini M, Coppola A, Molinari AC, Santoro C, Schinco P, Speciale V, Tagliaferri A.

Haemophilia. 2009 Mar;15(2):578-86. doi: 10.1111/j.1365-2516.2008.01975.x. Epub 2009 Feb 1.

PMID:
19187188
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk